List view / Grid view
2 December 2014 | By Exco InTouch
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, will speak in two mHealth Solutions sessions focused on disease management at the annual mHealth Summit on Monday, 8th and Tuesday 9th December 2014...
2 December 2014 | By Roche
Roche announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa), a privately-held company based in San Jose, California, USA...
2 December 2014 | By The Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation marked World AIDS Day by announcing 12 new grants totaling $1.47 million that focus on strengthening community-based services in sub-Saharan Africa for adolescents and the elderly who are living with HIV and for HIV patients with comorbid female cancers or tuberculosis...
2 December 2014 | By MWV
Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials...
1 December 2014 | By Kakushin Webinars
Dr. Gurpreet Sandhu, Reva Pharmachem Managing Director, shared the following in regard to Drug Manufacturing in Russia...
1 December 2014 | By Janssen-Cilag International
Janssen-Cilag International NV (Janssen) announced today the submission of a Type II variation application to the European Medicines Agency (EMA) to vary the marketing authorisation for IMBRUVICA® (ibrutinib), to include a new therapeutic indication, the treatment of adult patients with Waldenström’s macroglobulinemia (WM). If approved, this latest regulatory submission will…
1 December 2014 | By Arthurian Life Sciences
Arthurian Life Sciences, the specialist fund management company led by Professor Sir Chris Evans, announced it has formed a partnership with one of the leading medtech firms in the US, Interrad Medical Inc...
1 December 2014 | By Treeway
Treeway B.V. is pleased to announce that the European Medicines Agency has granted orphan drug designation for TW001 for the treatment of ALS...
1 December 2014 | By Futura Medical
Futura Medical plc, the innovative healthcare company focused on advanced transdermal technology, is pleased to announce that it will shortly be making a submission to UK regulators for approval to begin a clinical study to assess the efficacy and safety of its three topical pain relief products, which have already…
28 November 2014 | By Public Health England
Almost two months since the launch of the seasonal flu vaccine campaign, the first monthly uptake figures show an encouraging start, but Public Health England (PHE) is urging all at risk people not to ‘put off’ getting the vaccination until flu is circulating more widely...
27 November 2014 | By ViiV Healthcare
Landmark number of grants awarded for 2015 as the Positive Action for Children Fund hits 5 year milestone...
27 November 2014 | By Public Health England
Recent reports of meningitis and septicaemia cases in students...
27 November 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced that the European Commission has granted EU marketing authorisation for Vargatef® (nintedanib*), valid for the 28 countries within the EU...
27 November 2014 | By Bristol-Myers Squibb
Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for daclatasvir, an NS5A complex inhibitor, in combination with other agents for the treatment of hepatitis C...
27 November 2014 | By European Alcohol Policy Alliance
Today over 300 representatives from Health Ministries, the European Institutions, public health experts and concerned stakeholders have gathered in Brussels to call on the European Commission President Jean-Claude Juncker and his team to take actions to prevent and reduce the burden of alcohol on European societies...
